Product details

This is the first of a three-case series (303-221-1 to 303-223-1). The cases concern Schering AG, a multinational pharmaceutical company headquartered in Berlin, Germany. The case provides an overview of Schering''s business units (gynaecology and andrology, diagnostics and radiopharmaceuticals, specialised therapeutics, dermatology) and an introduction into pharmaceutical research and development and Schering''s R&D. Schering''s official strategy, its global matrix organisation and its strategic management process are also explained. The case may be used in graduate MBA and executive level courses in corporate strategy, strategy, international management, and strategy relating to pharmaceuticals and biotechnology. It may be used alone or with the other two cases (B) and (C) which are aimed at business level strategy.